Desa Nastasijević-Borovac
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Desa Nastasijević-Borovac has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Borislav Božanić
3 shared publicationsDragana Stojiljković
3 shared publicationsJelena Aleksić
3 shared publicationsKristina Jović
3 shared publications- Milan Radović
ICU Unit, Clinic for Pulmology, University Clinical Center of Niš, Niš 2Department for Internal Medicine and Paatient Care, Medical Faculty Niš, University of Niš, Niš
3 shared publications Stefan Šajnović
3 shared publications
Latest Publications
- Open Access
- 30 April 2026
- Published by University of Nis in Facta Universitatis, Series: Medicine and Biology
- p. 042-049
IMPORTANCE OF NUTRITIONAL INTERVENTIONS FOLLOWING NUTRITIONAL RISK SCREENING IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Medical nutritional therapy, both in its narrower medical sense and in its broader translational sense, serves as a complementary intervention for patients with COPD. Because any condition that impairs pulmonary function consequently affects the function of several other organs and systems, it often reduces the patient's ability to consume sufficient food to maintain body mass and muscle strength. The purpose of this review is to provide an overview of current methods for assessing the risk of malnutrition in hospitalized COPD patients, as well as to outline the most effective clinical approaches to initial medical nutritional therapy interventions aimed at preventing an unfavorable course of the disease. Nutritional screening is the first step in providing adequate medical nutritional therapy, since most COPD patients ultimately experience nutritional collapse with the onset and progression of malnutrition syndrome. Classifying patients according to their level of nutritional risk supports the assessment of nutritional status and the planning of medical, nutritional therapy, and care measures, thereby reducing the frequency of malnutrition-related adverse outcomes. Transthyretin (TTR), C-reactive protein (CRP), albumin, and ferritin are valid parameters for assessing patient nutritional status. Patients with COPD who are classified as having increased nutritional risk achieve better treatment outcomes – specifically lower rates of intrahospital infections, fewer overall complications, and reduced mortality - when medical, nutritional therapy is initiated immediately upon hospital admission treatment and/or during the perioperative period, compared to patients with low nutritional risk.
- 30 April 2026
- Published by University of Nis in Facta Universitatis, Series: Medicine and Biology
- p. 042-049
Open AccessIMPORTANCE OF NUTRITIONAL INTERVENTIONS FOLLOWING NUTRITIONAL RISK SCREENING IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Medical nutritional therapy, both in its narrower medical sense and in its broader translational sense, serves as a complementary intervention for patients with COPD. Because any condition that impairs pulmonary function consequently affects the function of several other organs and systems, it often reduces the patient's ability to consume sufficient food to maintain body mass and muscle strength. The purpose of this review is to provide an overview of current methods for assessing the risk of malnutrition in hospitalized COPD patients, as well as to outline the most effective clinical approaches to initial medical nutritional therapy interventions aimed at preventing an unfavorable course of the disease. Nutritional screening is the first step in providing adequate medical nutritional therapy, since most COPD patients ultimately experience nutritional collapse with the onset and progression of malnutrition syndrome. Classifying patients according to their level of nutritional risk supports the assessment of nutritional status and the planning of medical, nutritional therapy, and care measures, thereby reducing the frequency of malnutrition-related adverse outcomes. Transthyretin (TTR), C-reactive protein (CRP), albumin, and ferritin are valid parameters for assessing patient nutritional status. Patients with COPD who are classified as having increased nutritional risk achieve better treatment outcomes – specifically lower rates of intrahospital infections, fewer overall complications, and reduced mortality - when medical, nutritional therapy is initiated immediately upon hospital admission treatment and/or during the perioperative period, compared to patients with low nutritional risk.
- 1 January 2026
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Respiratio
- Vol. 16 (1-2) , 9-14
Therapeutic effects of reslizumab in patients with severe eosinophilic asthma
Introduction: The beneficial therapeutic effects of anti-IL-5 biological therapy in severe asthma have been confirmed in randomized controlled trials. The aim of this study was to evaluate the effects of reslizumab therapy in patients with severe eosinophilic asthma. Methods: This retrospective-prospective study included 18 patients. The following parameters were analyzed: age, body mass index (BMI), and the number of administered doses of biological therapy; absolute peripheral blood eosinophil count - BEC (cells/μL), at baseline and after three months of therapy; baseline fractional exhaled nitric oxide (FeNO) levels and total IgE levels; as well as prebronchodilator FEV₁ and Asthma Control Test (ACT) scores, at baseline and during twelve months of therapy. Results: All patients in the study group were female, with a mean age of 53.9 years and a mean BMI of 29.1 kg/m². An average of 12.25 doses of the drug was administered. The baseline BEC was 402.3 cells/ μL; administration of the first dose resulted in a statistically significant reduction after 24 hours, which was maintained after three months of follow-up. The mean FeNO value was 30.1 ppb, and the mean total IgE level was 160.9 IU/mL. The mean baseline FEV₁ was 57.7% of predicted, with higher values maintained throughout the follow-up period. The mean ACT score before initiation of therapy was 10.8 and was significantly higher during further follow-up. Conclusion: Biological therapy with reslizumab in overweight and obese female patients with a confirmed diagnosis of severe asthma and elevated biomarkers of the Th2 immune response results in a significant reduction in symptoms and stabilization of lung function, achieving adequate disease control in more than three-quarters of patients. The therapeutic effects are maintained over a one-year follow-up period.
- 1 January 2026
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Respiratio
- Vol. 16 (1-2) , 9-14
Therapeutic effects of reslizumab in patients with severe eosinophilic asthma
Introduction: The beneficial therapeutic effects of anti-IL-5 biological therapy in severe asthma have been confirmed in randomized controlled trials. The aim of this study was to evaluate the effects of reslizumab therapy in patients with severe eosinophilic asthma. Methods: This retrospective-prospective study included 18 patients. The following parameters were analyzed: age, body mass index (BMI), and the number of administered doses of biological therapy; absolute peripheral blood eosinophil count - BEC (cells/μL), at baseline and after three months of therapy; baseline fractional exhaled nitric oxide (FeNO) levels and total IgE levels; as well as prebronchodilator FEV₁ and Asthma Control Test (ACT) scores, at baseline and during twelve months of therapy. Results: All patients in the study group were female, with a mean age of 53.9 years and a mean BMI of 29.1 kg/m². An average of 12.25 doses of the drug was administered. The baseline BEC was 402.3 cells/ μL; administration of the first dose resulted in a statistically significant reduction after 24 hours, which was maintained after three months of follow-up. The mean FeNO value was 30.1 ppb, and the mean total IgE level was 160.9 IU/mL. The mean baseline FEV₁ was 57.7% of predicted, with higher values maintained throughout the follow-up period. The mean ACT score before initiation of therapy was 10.8 and was significantly higher during further follow-up. Conclusion: Biological therapy with reslizumab in overweight and obese female patients with a confirmed diagnosis of severe asthma and elevated biomarkers of the Th2 immune response results in a significant reduction in symptoms and stabilization of lung function, achieving adequate disease control in more than three-quarters of patients. The therapeutic effects are maintained over a one-year follow-up period.
- 1 January 2026
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Respiratio
- Vol. 16 (1-2) , 95-102
The significance of STOP-BANG, Epworth and Berlin questionnaires in predicting obstructive sleep apnea confirmed by respiratory poligraphy
Introduction: Obstructive sleep apnea (OSA) is a common sleep-disordered breathing disorder whose diagnosis requires polysomnography, which sometimes limits availability. The aim: To determine the diagnostic value of the STOP-BANG questionnaire, Epworth Sleepiness Scale (ESS), and Berlin Questionnaire in predicting OSA severity confirmed by respiratory polygraphy. Methods: A retrospective analysis included 105 patients with diagnosed OSA (AHI ≥ 5) treated at the Pulmonology Clinic of the University Hospital Center Niš. Results: The mean age was 52.95 ± 11.25 years, BMI 34.85 ± 6.68 kg/m², and the mean AHI 34.20 ± 21.13 events/h. Severe OSA was present in 53.3% of the subjects. All three questionnaires showed a statistically significant correlation with AHI (Spearman r = 0.361-0.370, p < 0.001). For the prediction of moderate to severe OSA (AHI ≥ 15), STOP-BANG with a threshold of ≥ 5 had the best AUC of 0.759, sensitivity of 90.5% and specificity of 38.1%. For the prediction of severe OSA (AHI ≥ 30), ESS showed the best AUC of 0.704 with balanced sensitivity (66.1%) and specificity (61.2%). The Berlin questionnaire had high sensitivity (92.9%) but low specificity for both severity levels. The optimal thresholds according to the Youden index differed from the standard ones: ESS ≥ 7 for moderate to severe, ≥ 12 for severe OSA; STOP-BANG ≥ 7 for both levels. Conclusion: STOP-BANG questionnaire with a threshold of ≥ 5 is the most useful screening tool for the identification of moderate to severe OSA, while ESS has the best performance for the prediction of severe OSA.
- 1 January 2026
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Respiratio
- Vol. 16 (1-2) , 95-102
The significance of STOP-BANG, Epworth and Berlin questionnaires in predicting obstructive sleep apnea confirmed by respiratory poligraphy
Introduction: Obstructive sleep apnea (OSA) is a common sleep-disordered breathing disorder whose diagnosis requires polysomnography, which sometimes limits availability. The aim: To determine the diagnostic value of the STOP-BANG questionnaire, Epworth Sleepiness Scale (ESS), and Berlin Questionnaire in predicting OSA severity confirmed by respiratory polygraphy. Methods: A retrospective analysis included 105 patients with diagnosed OSA (AHI ≥ 5) treated at the Pulmonology Clinic of the University Hospital Center Niš. Results: The mean age was 52.95 ± 11.25 years, BMI 34.85 ± 6.68 kg/m², and the mean AHI 34.20 ± 21.13 events/h. Severe OSA was present in 53.3% of the subjects. All three questionnaires showed a statistically significant correlation with AHI (Spearman r = 0.361-0.370, p < 0.001). For the prediction of moderate to severe OSA (AHI ≥ 15), STOP-BANG with a threshold of ≥ 5 had the best AUC of 0.759, sensitivity of 90.5% and specificity of 38.1%. For the prediction of severe OSA (AHI ≥ 30), ESS showed the best AUC of 0.704 with balanced sensitivity (66.1%) and specificity (61.2%). The Berlin questionnaire had high sensitivity (92.9%) but low specificity for both severity levels. The optimal thresholds according to the Youden index differed from the standard ones: ESS ≥ 7 for moderate to severe, ≥ 12 for severe OSA; STOP-BANG ≥ 7 for both levels. Conclusion: STOP-BANG questionnaire with a threshold of ≥ 5 is the most useful screening tool for the identification of moderate to severe OSA, while ESS has the best performance for the prediction of severe OSA.
- 1 January 2026
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Respiratio
- Vol. 16 (1-2) , 142-149
Serum vitamin D levels in relation to asthma severity, lung function, and type 2 inflammatory biomarkers
Introduction: Vitamin D has important immunomodulatory effects and may play a role in asthma pathophysiology; however, its impact on clinical outcomes remains unclear. The objective of this study was to evaluate the association between serum vitamin D levels and asthma severity, lung function, disease control, and type 2 inflammatory markers. Methods: This prospective cross-sectional study included 60 asthma patients divided into severe (n=30) and mild-to-moderate (n=30) groups. Serum vitamin D levels, FEV₁, ACT score, blood eosinophils, and total IgE were analyzed. Results: Patients with severe asthma had significantly lower vitamin D levels (p=0.008), lower FEV₁ and ACT scores, and higher eosinophil counts. Vitamin D deficiency was significantly more frequent in this group (83.3% vs 56.7%; p=0.047; OR=3.82). A positive correlation was observed between vitamin D levels and FEV₁ (ρ=0.306; p=0.018), as well as ACT score (ρ=0.368; p=0.004), while correlations with eosinophils and IgE were not statistically significant. Conclusion: Lower serum vitamin D levels are associated with greater asthma severity, impaired lung function, and poorer disease control. Vitamin D may act as a disease modifier, although further longitudinal and interventional studies are needed to clarify causality.
- 1 January 2026
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Respiratio
- Vol. 16 (1-2) , 142-149
Serum vitamin D levels in relation to asthma severity, lung function, and type 2 inflammatory biomarkers
Introduction: Vitamin D has important immunomodulatory effects and may play a role in asthma pathophysiology; however, its impact on clinical outcomes remains unclear. The objective of this study was to evaluate the association between serum vitamin D levels and asthma severity, lung function, disease control, and type 2 inflammatory markers. Methods: This prospective cross-sectional study included 60 asthma patients divided into severe (n=30) and mild-to-moderate (n=30) groups. Serum vitamin D levels, FEV₁, ACT score, blood eosinophils, and total IgE were analyzed. Results: Patients with severe asthma had significantly lower vitamin D levels (p=0.008), lower FEV₁ and ACT scores, and higher eosinophil counts. Vitamin D deficiency was significantly more frequent in this group (83.3% vs 56.7%; p=0.047; OR=3.82). A positive correlation was observed between vitamin D levels and FEV₁ (ρ=0.306; p=0.018), as well as ACT score (ρ=0.368; p=0.004), while correlations with eosinophils and IgE were not statistically significant. Conclusion: Lower serum vitamin D levels are associated with greater asthma severity, impaired lung function, and poorer disease control. Vitamin D may act as a disease modifier, although further longitudinal and interventional studies are needed to clarify causality.
- 1 January 2026
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Zdravstvena zastita
- Vol. 55 (1) , 8-20
Global geography of infective endocarditis pathogens: Etiology and resistance in the 21st century
Introduction/Aim: The etiology of infective endocarditis is diverse and complex. It varies significantly depending on geographical region, socioeconomic conditions, healthcare availability, and the prevalence of predisposing factors. The aim of this paper is to analyze the global geographical distribution of infective endocarditis pathogens in the 21st century, focusing on regional differences in etiology, diagnostics, therapy, and antimicrobial resistance. Methods: A secondary data analysis was conducted. Descriptive statistics were used to quantify pathogen frequency, the prevalence of resistant strains, and regional etiological differences. Results: In developed regions (North America and Western Europe), Staphylococcus aureus predominates, often associated with healthcare settings (30-35%) and high rates of MRSA resistance (up to 28%). Conversely, in developing countries, streptococci remain more prevalent, alongside the persistence of rheumatic heart disease. The availability of transesophageal echocardiography (TEE) and surgical treatment is significantly higher in developed countries, which directly contributes to a lower mortality rate (14-15%) compared to resource-limited regions (22%). Conclusion: Infective endocarditis has evolved into a disease associated with modern medicine and aging populations in developed countries, while in the rest of the world, it remains strongly associated with low socioeconomic conditions. High mortality and increasing resistance necessitate the global standardization of diagnostics and locally adapted therapeutic strategies.
- 1 January 2026
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Zdravstvena zastita
- Vol. 55 (1) , 8-20
Global geography of infective endocarditis pathogens: Etiology and resistance in the 21st century
Introduction/Aim: The etiology of infective endocarditis is diverse and complex. It varies significantly depending on geographical region, socioeconomic conditions, healthcare availability, and the prevalence of predisposing factors. The aim of this paper is to analyze the global geographical distribution of infective endocarditis pathogens in the 21st century, focusing on regional differences in etiology, diagnostics, therapy, and antimicrobial resistance. Methods: A secondary data analysis was conducted. Descriptive statistics were used to quantify pathogen frequency, the prevalence of resistant strains, and regional etiological differences. Results: In developed regions (North America and Western Europe), Staphylococcus aureus predominates, often associated with healthcare settings (30-35%) and high rates of MRSA resistance (up to 28%). Conversely, in developing countries, streptococci remain more prevalent, alongside the persistence of rheumatic heart disease. The availability of transesophageal echocardiography (TEE) and surgical treatment is significantly higher in developed countries, which directly contributes to a lower mortality rate (14-15%) compared to resource-limited regions (22%). Conclusion: Infective endocarditis has evolved into a disease associated with modern medicine and aging populations in developed countries, while in the rest of the world, it remains strongly associated with low socioeconomic conditions. High mortality and increasing resistance necessitate the global standardization of diagnostics and locally adapted therapeutic strategies.